Significance and Regional Dependency of Peptide Transporter (PEPT) 1 in the Intestinal Permeability of Glycylsarcosine: In Situ Single-Pass Perfusion Studies in Wild-Type and Pept1 Knockout Mice

被引:75
作者
Jappar, Dilara [1 ]
Wu, Shu-Pei [1 ]
Hu, Yongjun [1 ]
Smith, David E. [1 ]
机构
[1] Univ Michigan, Dept Pharmaceut Sci, Coll Pharm, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
BETA-LACTAM ANTIBIOTICS; COTRANSPORTER FAMILY; DIPEPTIDE TRANSPORT; TARGETED DISRUPTION; ABSORPTION; PH; EXPRESSION; CEPHALOSPORINS; CLONING; HPEPT1;
D O I
10.1124/dmd.110.034025
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to evaluate the role, relevance, and regional dependence of peptide transporter (PEPT) 1 expression and function in mouse intestines using the model dipeptide glycylsarcosine (GlySar). After isolating specific intestinal segments, in situ single-pass perfusions were performed in wild-type and Pept1 knockout mice. The permeability of [H-3]GlySar was measured as a function of perfusate pH, dipeptide concentration, potential inhibitors, and intestinal segment, along with PEPT1 mRNA and protein. We found the permeability of GlySar to be saturable (K-m = 5.7 mM), pH-dependent (maximal value at pH 5.5), and specific for PEPT1; other peptide transporters, such as PHT1 and PHT2, were not involved, as judged by the lack of GlySar inhibition by excess concentrations of histidine. GlySar permeabilities were comparable in the duodenum and jejunum of wild-type mice but were much larger than that in ileum (approximately 2-fold). A PEPT1-mediated permeability was not observed for GlySar in the colon of wild-type mice (<10% residual uptake compared to proximal small intestine). Moreover, GlySar permeabilities were very low and not different in the duodenum, jejunum, ileum, and colon of Pept1 knockout mice. Functional activity of intestinal PEPT1 was confirmed by real-time polymerase chain reaction and immunoblot analyses. Our findings suggest that a loss of PEPT1 activity (e. g., due to polymorphisms, disease, or drug interactions) should have a major effect in reducing the intestinal absorption of di-/tripeptides, peptidomimetics, and peptide-like drugs.
引用
收藏
页码:1740 / 1746
页数:7
相关论文
共 41 条
[21]  
Jeong EJ, 2004, METHOD PHARMACOL TOX, P65
[22]   DETERMINATION OF INTRINSIC MEMBRANE-TRANSPORT PARAMETERS FROM PERFUSED INTESTINE EXPERIMENTS - A BOUNDARY-LAYER APPROACH TO ESTIMATING THE AQUEOUS AND UNBIASED MEMBRANE PERMEABILITIES [J].
JOHNSON, DA ;
AMIDON, GL .
JOURNAL OF THEORETICAL BIOLOGY, 1988, 131 (01) :93-106
[23]   Comparative gene expression profiles of intestinal transporters in mice, rats and humans [J].
Kim, Hye-Ryoung ;
Park, Sung-Won ;
Cho, Hee-Jung ;
Chae, Kyung-Ae ;
Sung, Ji-Min ;
Kim, Jin-Suk ;
Landowski, Christopher P. ;
Sun, Duxin ;
Abd El-Aty, A. M. ;
Amidon, Gordon L. ;
Shin, Ho-Chul .
PHARMACOLOGICAL RESEARCH, 2007, 56 (03) :224-236
[24]   QUANTITATIVE MECHANISTIC STUDIES IN SIMULTANEOUS FLUID-FLOW AND INTESTINAL-ABSORPTION USING STEROIDS AS MODEL SOLUTES [J].
KOMIYA, I ;
PARK, JY ;
KAMANI, A ;
HO, NFH ;
HIGUCHI, WI .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1980, 4 (03) :249-262
[25]   CALCULATION OF THE AQUEOUS DIFFUSION LAYER RESISTANCE FOR ABSORPTION IN A TUBE - APPLICATION TO INTESTINAL-MEMBRANE PERMEABILITY DETERMINATION [J].
KOU, JH ;
FLEISHER, D ;
AMIDON, GL .
PHARMACEUTICAL RESEARCH, 1991, 8 (03) :298-305
[26]   MOLECULAR-CLONING OF PEPT-2, A NEW MEMBER OF THE H+/PEPTIDE COTRANSPORTER FAMILY, FROM HUMAN KIDNEY [J].
LIU, W ;
LIANG, R ;
RAMAMOORTHY, S ;
FEI, YJ ;
GANAPATHY, ME ;
HEDIGER, MA ;
GANAPATHY, V ;
LEIBACH, FH .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1995, 1235 (02) :461-466
[27]   DETERMINATION OF ACID SURFACE PH INVIVO IN RAT PROXIMAL JEJUNUM [J].
LUCAS, M .
GUT, 1983, 24 (08) :734-739
[28]  
MATSUMOTO S, 1994, J PHARMACOL EXP THER, V270, P498
[29]  
Mirossay L, 1999, PHYSIOL RES, V48, P135
[30]   Role and relevance of peptide transporter 2 (PEPT2) in the kidney and choroid plexus: In vivo studies with glycylsarcosine in wild-type and PEPT2 knockout mice [J].
Ocheltree, SM ;
Shen, H ;
Hu, YJ ;
Keep, RF ;
Smith, DE .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (01) :240-247